Author: Craig Mathews

Filter by

News

Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation

Posted onFebruary 16, 2021 Last Updated: February 23, 2021
By: Craig Mathews

COVID

Just-Evotec Biologics expands COVID-19 contract with DOD

Posted onFebruary 8, 2021 Last Updated: February 23, 2021
By: Craig Mathews

News

Bristol Myers Squibb’s CAR-T liso-cel wins long-delayed FDA nod

Posted onFebruary 8, 2021 Last Updated: February 23, 2021
By: Craig Mathews

News

With $588M IPO, Sana leads wave of new biotechs going public

Posted onFebruary 8, 2021 Last Updated: February 8, 2021
By: Craig Mathews

Jobs

Seattle registers highest net gain in tech talent, CBRE study shows

Posted onFebruary 1, 2021 Last Updated: February 1, 2021
By: Craig Mathews

Funding

Seattle life science funding expected to be big in 2021

Posted onJanuary 29, 2021 Last Updated: January 29, 2021
By: Craig Mathews

News

UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

Posted onJanuary 19, 2021 Last Updated: January 19, 2021
By: Craig Mathews

News

AbSci purchases San Diego artificial intelligence startup Denovium

Posted onJanuary 19, 2021 Last Updated: January 19, 2021
By: Craig Mathews

News

Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body

Posted onJanuary 19, 2021 Last Updated: January 19, 2021
By: Craig Mathews

News

Seattle Startup Chases Alzheimer’s with $23 Million Series A

Posted onJanuary 18, 2021 Last Updated: January 18, 2021
By: Craig Mathews